McLeod Honored with Coriell Scientific Award

Howard McLeod, PharmD, is a recipient of a 2012 Coriell Personalized Medicine Research Award from the Coriell Institute for Medical Research. McLeod is a Fred Eshelman Distinguished Professor and director of the Institute for Pharmacogenomics and Individualized Therapy at the UNC Eshelman School of Pharmacy.

McLeod will be honored with Coriell’s Scientific Award at a reception on May 23 at the Union League of Philadelphia. The institute also presents a humanitarian award and an ambassador award.

As an internationally recognized expert in the field of pharmacogenomics, McLeod has helped identify genetic variations that predispose patients to risk of severe side effects or inadequate benefit from drugs. His research also modified FDA dosing guidelines for warfarin, a blood thinner prescribed to more than two million people in the United States.

The Camden, New Jersey–based Coriell institute is an independent nonprofit research center dedicated to the study of the human genome. The Coriell Personalized Medicine Collaborative research study is seeking to understand the usefulness of genetic risk and pharmacogenomics in clinical decision making and health-care management.